메뉴 건너뛰기




Volumn 12, Issue 6, 2016, Pages 5205-5210

Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old

Author keywords

Cancer; Cytokine induced killer cells; Dendritic cells; Immunotherapy

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CD56 ANTIGEN; CELL THERAPY AGENT; DENDRITIC CELL ACTIVATED CYTOKINE INDUCED KILLER CELL THERAPY AGENT; UNCLASSIFIED DRUG;

EID: 84995755299     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.5337     Document Type: Article
Times cited : (8)

References (25)
  • 1
    • 9444272941 scopus 로고    scopus 로고
    • Perceptions of older people with cancer of information, decision making and treatment: A systematic review of selected literature
    • Chouliara Z, Kearney N, Stott D, Molassiotis A and Miller M: Perceptions of older people with cancer of information, decision making and treatment: A systematic review of selected literature. Ann Oncol 15: 1596-1602, 2004.
    • (2004) Ann Oncol , vol.15 , pp. 1596-1602
    • Chouliara, Z.1    Kearney, N.2    Stott, D.3    Molassiotis, A.4    Miller, M.5
  • 5
    • 84898894700 scopus 로고    scopus 로고
    • A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients
    • Zhong R, Han B and Zhong H: A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients. Tumour Biol 35: 987-994, 2014.
    • (2014) Tumour Biol , vol.35 , pp. 987-994
    • Zhong, R.1    Han, B.2    Zhong, H.3
  • 7
    • 84875282081 scopus 로고    scopus 로고
    • Cytokine-induced killer cells promote antitumor immunity
    • Jiang J, Wu C and Lu B: Cytokine-induced killer cells promote antitumor immunity. J Transl Med 11: 83, 2013.
    • (2013) J Transl Med , vol.11 , pp. 83
    • Jiang, J.1    Wu, C.2    Lu, B.3
  • 8
    • 78751628167 scopus 로고    scopus 로고
    • Clinical trials on CIK cells: First report of the international registry on CIK cells (IRCC)
    • Hontscha C, Borck Y, Zhou H, Messmer D and Schmidt-Wolf IG: Clinical trials on CIK cells: First report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 137: 305-310, 2011.
    • (2011) J Cancer Res Clin Oncol , vol.137 , pp. 305-310
    • Hontscha, C.1    Borck, Y.2    Zhou, H.3    Messmer, D.4    Schmidt-Wolf, I.G.5
  • 11
    • 84883244302 scopus 로고    scopus 로고
    • Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo
    • Huang J, Li C, Wang Y, Lv H, Guo Y, Dai H, Wicha MS, Chang AE and Li Q: Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo. Clin Immunol 149: 156-168, 2013.
    • (2013) Clin Immunol , vol.149 , pp. 156-168
    • Huang, J.1    Li, C.2    Wang, Y.3    Lv, H.4    Guo, Y.5    Dai, H.6    Wicha, M.S.7    Chang, A.E.8    Li, Q.9
  • 12
    • 84864347928 scopus 로고    scopus 로고
    • The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: A clinical retrospective study
    • Zhang J, Zhu L, Wei J, Liu L, Yin Y, Gu Y and Shu Y: The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: A clinical retrospective study. J Cancer Res Clin Oncol 138: 1057-1062, 2012.
    • (2012) J Cancer Res Clin Oncol , vol.138 , pp. 1057-1062
    • Zhang, J.1    Zhu, L.2    Wei, J.3    Liu, L.4    Yin, Y.5    Gu, Y.6    Shu, Y.7
  • 13
    • 84855606037 scopus 로고    scopus 로고
    • Clinical study of autologous cytokine-induced killer cells for the treatment of elderly patients with diffuse large B-cell lymphoma
    • Lu XC, Yang B, Yu RL, Chi XH, Tuo S, Tuo CW, Zhu HL, Wang Y, Jiang CG, Fu XB, et al: Clinical study of autologous cytokine-induced killer cells for the treatment of elderly patients with diffuse large B-cell lymphoma. Cell Biochem Biophys 62: 257-265, 2012.
    • (2012) Cell Biochem Biophys , vol.62 , pp. 257-265
    • Lu, X.C.1    Yang, B.2    Yu, R.L.3    Chi, X.H.4    Tuo, S.5    Tuo, C.W.6    Zhu, H.L.7    Wang, Y.8    Jiang, C.G.9    Fu, X.B.10
  • 14
    • 84899116386 scopus 로고    scopus 로고
    • Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients
    • Gao D, Li C, Xie X, Zhao P, Wei X, Sun W, Liu HC, Alexandrou AT, Jones J, Zhao R and Li JJ: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients. PLoS One 9: e93886, 2014.
    • (2014) Plos One , vol.9
    • Gao, D.1    Li, C.2    Xie, X.3    Zhao, P.4    Wei, X.5    Sun, W.6    Liu, H.C.7    Alexandrou, A.T.8    Jones, J.9    Zhao, R.10    Li, J.J.11
  • 15
    • 84924231322 scopus 로고    scopus 로고
    • Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer
    • Zhao P, Bu X, Wei X, Sun W, Xie X, Li C, Guo Q, Zhu D, Wei X and Gao D: Dendritic cell immunotherapy combined with cytokine-induced killer cells promotes skewing toward Th2 cytokine profile in patients with metastatic non-small cell lung cancer. Int Immunopharmacol 25: 450-456, 2015.
    • (2015) Int Immunopharmacol , vol.25 , pp. 450-456
    • Zhao, P.1    Bu, X.2    Wei, X.3    Sun, W.4    Xie, X.5    Li, C.6    Guo, Q.7    Zhu, D.8    Wei, X.9    Gao, D.10
  • 16
    • 84872488982 scopus 로고    scopus 로고
    • Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients
    • Yang L, Ren B, Li H, Yu J, Cao S, Hao X and Ren X: Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients. Cancer Immunol Immunother 62: 65-73, 2013.
    • (2013) Cancer Immunol Immunother , vol.62 , pp. 65-73
    • Yang, L.1    Ren, B.2    Li, H.3    Yu, J.4    Cao, S.5    Hao, X.6    Ren, X.7
  • 19
    • 84890814629 scopus 로고    scopus 로고
    • Breakthrough of the year 2013. Cancer immunotherapy
    • Couzin-Frankel J: Breakthrough of the year 2013. Cancer immunotherapy. Science 342: 1432-1433, 2013.
    • (2013) Science , vol.342 , pp. 1432-1433
    • Couzin-Frankel, J.1
  • 20
    • 71149114221 scopus 로고    scopus 로고
    • Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery
    • Li H, Wang C, Yu J, Cao S, Wei F, Zhang W, Han Y and Ren XB: Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery. Cytotherapy 11: 1076-1083, 2009.
    • (2009) Cytotherapy , vol.11 , pp. 1076-1083
    • Li, H.1    Wang, C.2    Yu, J.3    Cao, S.4    Wei, F.5    Zhang, W.6    Han, Y.7    Ren, X.B.8
  • 21
    • 84890854644 scopus 로고    scopus 로고
    • Can the dual-functional capability of CIK cells be used to improve antitumor effects?
    • Wang X, Yu W, Li H, Yu J, Zhang X, Ren X and Cao S: Can the dual-functional capability of CIK cells be used to improve antitumor effects? Cell Immunol 287: 18-22, 2014.
    • (2014) Cell Immunol , vol.287 , pp. 18-22
    • Wang, X.1    Yu, W.2    Li, H.3    Yu, J.4    Zhang, X.5    Ren, X.6    Cao, S.7
  • 22
    • 84947504060 scopus 로고    scopus 로고
    • DCIR2+ cDC2 DCs and Zbtb32 restore CD4+ T cell tolerance and inhibit diabetes
    • Price JD, Hotta-Iwamura C, Zhao Y, Beauchamp NM and Tarbell KV: DCIR2+ cDC2 DCs and Zbtb32 restore CD4+ T cell tolerance and inhibit diabetes. Diabetes 64: 3521-3531, 2015.
    • (2015) Diabetes , vol.64 , pp. 3521-3531
    • Price, J.D.1    Hotta-Iwamura, C.2    Zhao, Y.3    Beauchamp, N.M.4    Tarbell, K.V.5
  • 23
    • 84931449915 scopus 로고    scopus 로고
    • Cytokine-induced killer (CIK) cells in cancer immunotherapy: Report of the international registry on CIK cells (IRCC)
    • Schmeel LC, Schmeel FC, Coch C and Schmidt-Wolf IG: Cytokine-induced killer (CIK) cells in cancer immunotherapy: Report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol 141: 839-849, 2015.
    • (2015) J Cancer Res Clin Oncol , vol.141 , pp. 839-849
    • Schmeel, L.C.1    Schmeel, F.C.2    Coch, C.3    Schmidt-Wolf, I.G.4
  • 24
    • 84940990114 scopus 로고    scopus 로고
    • Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer
    • Mao Q, Li L, Zhang C, Sun Y, Liu S and Cui S: Clinical effects of immunotherapy of DC-CIK combined with chemotherapy in treating patients with metastatic breast cancer. Pak J Pharm Sci 28 (Suppl 3): S1055-S1058, 2015.
    • (2015) Pak J Pharm Sci , vol.28 , pp. S1055-S1058
    • Mao, Q.1    Li, L.2    Zhang, C.3    Sun, Y.4    Liu, S.5    Cui, S.6
  • 25
    • 84930635662 scopus 로고    scopus 로고
    • Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer
    • Wang S and Wang Z: Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer. Int Immunopharmacol 28: 22-28, 2015.
    • (2015) Int Immunopharmacol , vol.28 , pp. 22-28
    • Wang, S.1    Wang, Z.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.